The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dolan Matthew Vincent since 2022.
This trader's CIK number is 1914994.
At the time of last reporting, Dolan Matthew Vincent was the EVP, Strategy & Corporate Dev of Dexcom Inc. (stock ticker symbol DXCM).
Also see all insider trading activities at Dexcom Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DXCM | 0 | $0 | 1,183 | $102,819 | 0 | $0 |
| 2024 | DXCM | 0 | $0 | 15,326 | $2,031,118 | 0 | $0 |
| 2023 | DXCM | 0 | $0 | 6,511 | $693,538 | 0 | $0 |
| 2022 | DXCM | 0 | $0 | 2,196 | $929,174 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-29 | DXCM | Sale | 1,183 | 86.91 | 102,819 |
| 2024-05-15 | DXCM | Sale | 2,423 | 126.58 | 306,703 |
| 2024-04-15 | DXCM | Sale | 1,990 | 137.81 | 274,241 |
| 2024-03-15 | DXCM | Sale | 4,203 | 130.45 | 548,277 |
| 2024-03-12 | DXCM | Sale | 6,710 | 134.41 | 901,897 |
| 2023-09-01 | DXCM | Sale | 56 | 102.32 | 5,729 |
| 2023-03-13 | DXCM | Sale | 6,229 | 106.27 | 661,955 |
| 2023-03-06 | DXCM | Sale | 226 | 114.40 | 25,854 |
| 2022-09-01 | DXCM | Sale | 5 | 81.63 | 408 |
| 2022-09-01 | DXCM | Sale | 5 | 81.63 | 408 |
| 2022-03-15 | DXCM | Sale | 1,016 | 412.41 | 419,008 |
| 2022-03-16 | DXCM | Sale | 686 | 425.00 | 291,550 |
| 2022-03-17 | DXCM | Sale | 484 | 450.00 | 217,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dolan Matthew Vincent (EVP, Strategy & Corporate Dev of Dexcom Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.